Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic
Abstract
Background Giardiasis is one of the most common enteric protozoal infections worldwide. It is frequently reported as an enteric parasitic infection in the United States of America (USA) and Europe, whereas reported incidence in Japan is substantially lower. This study characterized age-specific, geographic, and temporal patterns of reported giardiasis incidence in Japan, the USA, and Europe using publicly available surveillance data. Methodology/principal findings This retrospective study analyzed surveillance data from the National Institute of Infectious Diseases (NIID) in Japan, the Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC) to describe epidemiological patterns, possible explanatory factors, and temporal trends before and during the COVID-19 pandemic. Annual trends were examined using all available surveillance years: 2007–2023 for Japan and Europe and 2007–2022 for the USA. Age-specific patterns were compared between the pre-pandemic (2017–2019) and pandemic (2020–2022) periods, and geographic patterns were examined using available regional data. Incidence rates in the USA and Europe were approximately 5 per 100,000 population, whereas reported incidence in Japan remained below 0.1 per 100,000. Age-specific patterns differed: incidence peaked in children aged 0–14 years in Europe, and in children aged 0–4 years and adults aged 25–39 years in the USA, whereas in Japan, incidence was highest among adults aged 25–44 years and relatively high among those aged ≥65 years. Geographic patterns also differed, with higher incidence in Tokyo, Nordic and Baltic countries and selected European countries, and New England and Midwestern states. Annual incidence was significantly lower in the COVID-19-onset period than in the pre-COVID-19 period across all regions. Conclusions/significance These findings suggest that exposure patterns and possible explanatory factors differ by region and age group, highlighting the importance of region- and age-specific prevention strategies.
Related
- Population genetic insights into biogeography and clonality of the perennial Ambrosia psilostachya DC. (Asteraceae) in the United States of America
- Dietary tryptophan rescues growth impairment during giardiasis independently of parasite burden
- Serum IgE, IL-4 and IL-13 Concentrations as Th2-Associated Biomarkers in Canine Giardiasis.
- Bimekizumab for Darier disease: A case report highlighting dual IL-17A and IL-17F inhibition as a potential treatment.
- Ravulizumab monotherapy for anti-CFH antibody-associated aHUS in an elderly patient: a case report highlighting individualized clinical decision-making
BibTeX
@article{mori2026giardiasis,
title = {{Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic}},
author = {Hirotake Mori and Ryoko Makuuchi and Daria Krokva and Dmytro Remez and Rapeepun Prasertbun and Yoshiro Hadano and Supaluk Popruk and Aongart Mahittikorn and Rapeephan R. Maude and Dhammika Leshan Wannigama and Raita Tamaki and Gautam A. Deshpande and Roger Frutos and Chris Smith and Toshio Naito},
journal = {PLoS Neglected Tropical Diseases},
year = {2026},
month = oct,
doi = {10.1371/journal.pntd.0014428},
url = {https://hal.science/hal-05796352v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic
AU - Hirotake Mori
AU - Ryoko Makuuchi
AU - Daria Krokva
AU - Dmytro Remez
AU - Rapeepun Prasertbun
AU - Yoshiro Hadano
AU - Supaluk Popruk
AU - Aongart Mahittikorn
AU - Rapeephan R. Maude
AU - Dhammika Leshan Wannigama
AU - Raita Tamaki
AU - Gautam A. Deshpande
AU - Roger Frutos
AU - Chris Smith
AU - Toshio Naito
PY - 2026
DA - 2026/10/13
JO - PLoS Neglected Tropical Diseases
DO - 10.1371/journal.pntd.0014428
UR - https://hal.science/hal-05796352v1
AB - Background Giardiasis is one of the most common enteric protozoal infections worldwide. It is frequently reported as an enteric parasitic infection in the United States of America (USA) and Europe, whereas reported incidence in Japan is substantially lower. This study characterized age-specific, geographic, and temporal patterns of reported giardiasis incidence in Japan, the USA, and Europe using publicly available surveillance data. Methodology/principal findings This retrospective study analyzed surveillance data from the National Institute of Infectious Diseases (NIID) in Japan, the Centers for Disease Control and Prevention (CDC), and the European Centre for Disease Prevention and Control (ECDC) to describe epidemiological patterns, possible explanatory factors, and temporal trends before and during the COVID-19 pandemic. Annual trends were examined using all available surveillance years: 2007–2023 for Japan and Europe and 2007–2022 for the USA. Age-specific patterns were compared between the pre-pandemic (2017–2019) and pandemic (2020–2022) periods, and geographic patterns were examined using available regional data. Incidence rates in the USA and Europe were approximately 5 per 100,000 population, whereas reported incidence in Japan remained below 0.1 per 100,000. Age-specific patterns differed: incidence peaked in children aged 0–14 years in Europe, and in children aged 0–4 years and adults aged 25–39 years in the USA, whereas in Japan, incidence was highest among adults aged 25–44 years and relatively high among those aged ≥65 years. Geographic patterns also differed, with higher incidence in Tokyo, Nordic and Baltic countries and selected European countries, and New England and Midwestern states. Annual incidence was significantly lower in the COVID-19-onset period than in the pre-COVID-19 period across all regions. Conclusions/significance These findings suggest that exposure patterns and possible explanatory factors differ by region and age group, highlighting the importance of region- and age-specific prevention strategies.
SN - 1935-2727
SN - 1935-2735
ER -